Page last updated: 2024-11-08

schisantherin d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

schisantherin D: a lignan from the fruits of Schisandra sphenanthera [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Schisandra sphenantheraspecies[no description available]SchisandraceaeA plant family of the order AUSTROBAILEYALES, class MAGNOLIOPSIDA.[MeSH]

Cross-References

ID SourceID
PubMed CID163067
CHEMBL ID475880
MeSH IDM0218850

Synonyms (15)

Synonym
64917-82-4
schisantherin d
CHEMBL475880
cycloocta(1,2-f:3,4-f')bis(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-, 5-benzoate, stereoisomer
unii-9dkr8q4ezc
9dkr8q4ezc ,
cycloocta(1,2-f:3,4-f')bis(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-, 5-benzoate, (5s,6s,7s,13as)-
schizantherin d
shisantherin d
FS-8817
Q27272401
DTXSID901316924
[(11s,12s,13s)-12-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.02,10.04,8.017,21]docosa-1(22),2,4(8),9,15,17(21)-hexaen-11-yl] benzoate
CS-0133042
HY-N7543
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID399882Antiviral activity against HIV2004Journal of natural products, Feb, Volume: 67, Issue:2
Current developments in the discovery and design of new drug candidates from plant natural product leads.
AID569567Therapeutic index, ratio of CC50 for human C1866 cells to EC50 for HIV1-3B2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID569566Antiviral activity against HIV1-3B infected in human C1866 cells assessed as inhibition of virus-induced cytopathic effect2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID354616Therapeutic index, ratio of IC50 for mock-infected human H9 cells to EC50 for HIV1 3B1996Journal of natural products, Nov, Volume: 59, Issue:11
Two new lignans, interiotherins A and B, as anti-HIV principles from Kadsura interior.
AID569565Cytotoxicity against human C1866 cells2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID354614Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 antigen production after 4 days by ELISA1996Journal of natural products, Nov, Volume: 59, Issue:11
Two new lignans, interiotherins A and B, as anti-HIV principles from Kadsura interior.
AID354615Cytotoxicity against mock-infected human H9 cells after 4 days1996Journal of natural products, Nov, Volume: 59, Issue:11
Two new lignans, interiotherins A and B, as anti-HIV principles from Kadsura interior.
AID724310Inhibition of NF-kappaB (unknown origin) expressed in TNFalpha-stimulated rat HSC-T6 cells assessed as reduction of HSC activation at 50 ug/ml treated 30 mins before TNFalpha stimulation measured after 6 hrs by bioluminescence based luciferase reporter ge2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Anti-liver fibrotic lignans from the fruits of Schisandra arisanensis and Schisandra sphenanthera.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]